Question follow-through · 130024
ME/CFS: Health Services
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that integrated care boards are held accountable for commissioning services for those with very severe ME/CFS the absence of a national specialise
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 27 Apr 2026
- Target answer date
- 29 Apr 2026
- Answer
- 29 Apr 2026 · 2 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Dementia: Health Services · 3 Jun 2026
- Restless Legs Syndrome: Drugs · 5 Jun 2026
- Drugs: Side Effects · 10 Jun 2026
- Drugs: Side Effects · 10 Jun 2026
- Drugs: Side Effects · 10 Jun 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
27 Apr 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure that integrated care boards are held accountable for commissioning services for those with very severe ME/CFS the absence of a national specialise
29 Apr 2026
Target answer date
Date supplied by the official written-questions record.
29 Apr 2026
Answer published
Integrated care boards (ICBs) are expected to commission services for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) across all levels of severity, including those with severe and very severe ME/CFS, in line with national standard...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Dementia: Health Services
3 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people with complex dementia needs, including those requiring one-to-one support, can access safe and suitable care placements following discharge
Restless Legs Syndrome: Drugs
5 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients prescribed dopamine agonists are informed about the risk of impulse control disorders.
Drugs: Side Effects
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, how many Yellow Card reports have (a) listed pramipexole, ropinirole, rotigotine and cabergoline as a suspected medicine and (b) included any reaction term relating to impulse control disorders, in
Drugs: Side Effects
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of patients exposed to dopamine agonists for (a) Parkinson’s disease and (b) restless legs syndrome; and what comparison the Department has made
Drugs: Side Effects
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the extent of under-reporting of dopamine agonist-related impulse control disorders to the Yellow Card scheme; and what steps it is taking to improv
Drugs: Side Effects
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, what data his Department and the Medicines and Healthcare products Regulatory Agency holds on how many and what proportion of patients develop withdrawal symptoms, including dopamine agonist withdr
Drugs: Side Effects
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the typical duration and severity of withdrawal symptoms associated with dopamine agonist dose reduction or discontinuation; and how those outcomes vary b
Drugs: Side Effects
10 Jun 2026 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number and proportion of patients who, having developed impulse control disorders while taking dopamine agonists and attempted withdrawal, subsequently
Drugs: Side Effects
11 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential financial impact of dopamine agonist-related impulse control disorders on those experiencing such disorders, including through (a) gambling-
Drugs: Side Effects
11 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of dopamine agonist-related impulse control disorders and augmentation in people with restless legs syndrome and Parkinson’s disease
Drugs: Side Effects
11 Jun 2026 · To ask the Secretary of State for Health and Social Care, what data the Department holds on the number and proportion of dopamine agonist-treated patients with impulse control disorders who experience relationship breakdown or divorce.
Drugs: Side Effects
11 Jun 2026 · To ask the Secretary of State for Health and Social Care, what assessment the Department has made of the level of suicides and attempted suicides among (a) people prescribed dopamine agonists who have experienced impulse control disorders, augmentation or